Venture Investors
Venture Investors is a premier provider of seed and early stage venture capital in the Midwest.
Business Model:
Revenue: $10M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Venture Investors Information
Geographic Data
Address: 505 S Rosa Rd
City: Madison
State: WI
Zip: 53719
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$100M
Social
Twitter
Linkedin
Crunchbase
Metrics
9,480,362Website Global Rank
147Website Monthly Traffic
Twitter Followers
Description
Turning innovation into health. Venture Investors seeks the next big things in healthcare. Based in the Midwest with open access to renowned research universities, and the vibrant communities that surround them, we target, uncover, and invest in extraordinary ideas that will shape the future of health and wellness. With decades of proven success, we’re fueling the future of what’s driving healthcare. Today, we have over $200 million in assets under management.
Contact Phone:
+16084412700
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2000 | Alfalight | Series A | 6.1M |
| 5/2007 | ProCertus BioPharm | Series A | 2.3M |
| 7/2009 | ProCertus BioPharm | Venture Round | 2.1M |
| 1/2014 | Madison Vaccines | Series A | 8M |
| 7/2000 | SoftSwitching Technologies | Series B | 6.2M |
| 4/2011 | Akebia Therapeutics | Series B | 0 |
| 1/2017 | Madison Vaccines | Venture Round | 3.3M |
| 6/2020 | EnsoData | Series A | 9M |
| 8/2015 | ReShape Lifesciences | Post-IPO Equity | 38M |
| 3/2015 | Madison Vaccines | Series A | 3M |
| 9/2014 | Prevacept Infection Control | Venture Round | 0 |
| 9/2015 | Delphinus Medical Technologies | Series C | 0 |
| 1/2017 | TAI Diagnostics | Venture Round | 1.8M |
| 11/2012 | BlueWillow Biologics | Series C | 0 |
| 1/2012 | Aerpio Pharmaceuticals | Venture Round | 5M |
| 1/2015 | Silatronix | Venture Round | 2.1M |
| 5/2015 | NeuWave Medical | Series C | 25.3M |
| 2/2020 | Eximis Surgical | Series A | 17M |
| 7/2009 | Akebia Therapeutics | Series A | 25M |
| 9/2002 | InterSymbol Communications | Series A | 5M |
| 6/2020 | HistoSonics | Series C | 40M |
| 1/2008 | Pattern Insight | Series A | 3M |
| 12/2002 | Chromatin | Series A | 0 |
| 4/2006 | Chromatin | Venture Round | 0 |
| 10/2015 | TAI Diagnostics | Series A | 8.2M |
| 8/2013 | Tissue Regeneration Systems | Series B | 4.6M |
| 5/2014 | HistoSonics | Series A | - |
| 2/2014 | UpTo | Series A | 670k |
| 5/2008 | Silatronix | Seed Round | 500k |
| 9/2022 | Delphinus Medical Technologies | Series D | 0 |
| 3/2007 | Mithridion | Series A | 2.2M |
| 2/2008 | NeuWave Medical | Series A | 4.5M |
| 12/1984 | Promega | Venture Round | - |
| 4/2022 | EnsoData | Series A | 0 |
| 2/2008 | NERITES | Series A | 5.7M |
| 5/2008 | Tissue Regeneration Systems | Series A | 2M |
| 12/2004 | Zystor | Series A | 0 |
| 1/2015 | Thalchemy | Funding Round | 250k |
| 6/2014 | Thalchemy | Seed | 650k |
| 5/2016 | FluGen | Venture Round | 0 |
| 12/2019 | SkySpecs | Series C | 0 |
| 9/2007 | Virent Energy Systems | Series B | 0 |
| 7/2009 | BlueWillow Biologics | Series B | 0 |
| 4/2017 | FluGen | Series A | 0 |
| 8/2015 | FluGen | Series A | 0 |
| 3/2017 | HistoSonics | Series B | 0 |
| 2/2010 | HistoSonics | Series A | 0 |
| 1/2011 | Celleration | Series E | 0 |
| 3/2001 | Corona Optical Systems | Series A | 12.1M |
| 11/2018 | Eximis Surgical | Venture Round | 7.5M |
| 4/2003 | Roche NimbleGen | Series D | 0 |
| 4/2014 | Aerpio Pharmaceuticals | Series C | 0 |
| 3/2017 | Aerpio Pharmaceuticals | Venture Round | 0 |
| 11/2004 | Roche NimbleGen | Series F | 12.8M |
| 1/2017 | Elucent Medical | Series A | 7.2M |
| 4/2014 | Neurovance | Series A | 6.3M |
| 9/2015 | Silatronix | Venture Round | 0 |
| 11/2013 | Silatronix | Venture Round | 0 |
| 7/2000 | Gala Biotech | Venture Round | 0 |
| 10/2001 | Roche NimbleGen | Series B | 10.5M |
| 7/2012 | Juventas Therapeutics | Series B | 0 |
| 10/2009 | Inviragen | Series A | 0 |
| 7/2002 | Celleration | Series B | 0 |
| 7/1994 | Third Wave Technologies | Series A | 300k |
| 12/2007 | Deltanoid Pharmaceuticals | Series B | 12M |
| 11/2015 | SkySpecs | Series A | 0 |
| 1/2009 | Mithridion | Series B | 2.9M |
| 1/2011 | Mithridion | Series C | 1.3M |
| 4/2014 | NeuMoDx Molecular | Series B | 21M |
| 11/2021 | ViaLase | Series A | 27.3M |
| 12/2022 | HistoSonics | Convertible Note | 85M |
| 3/2011 | Euthymics Bioscience | Series A | 4M |
| 4/2013 | Netsocket | Series B | 9.2M |
| 4/2019 | HistoSonics | Series C | 0 |
| 3/2009 | LensX Lasers | Series B | 22.4M |
| 11/2013 | Aerpio Pharmaceuticals | Series A | 0 |
| 6/2006 | Virent Energy Systems | Series A | 0 |
| 6/2016 | Silatronix | Venture Round | 8M |
| 1/2008 | Cellectar Biosciences | Venture Round | 13M |
| 1/2020 | Health Scholars | Series B | 0 |
| 6/2013 | UpTo | Series A | 2M |
| 1/2015 | Silatronix | Funding Round | 2.1M |
| 2/1999 | TomoTherapy | Series A | 3M |
| 1/2014 | Cellectar Biosciences | Post-IPO Equity | 4M |
| 3/2015 | HealthMyne | Series A | 4.5M |
| 8/2018 | HealthMyne | Series B | 15M |
| 1/2018 | SkySpecs | Series B | 0 |
| 6/2013 | Akebia Therapeutics | Series C | 0 |
| 8/2017 | HealthMyne | Series A | - |
| 9/2016 | HealthMyne | Venture Round | 6.9M |
| 10/2012 | ReShape Lifesciences | Post-IPO Equity | 15M |
| 4/2007 | Incept BioSystems | Series A | 3.3M |
| 8/2012 | NeuWave Medical | Equity | 14M |
| 6/2015 | Neurovance | Series A | 6.5M |
| 10/2000 | IntraLase | Venture Round | 22M |
| 10/2018 | Invenra | Series B | 0 |
| 6/2013 | Getnextt | Seed Round | 700k |
| 4/2022 | EnsoData | Series A | 0 |
| 11/2021 | ViaLase | Series A | 0 |
| 6/2020 | EnsoData | Series A | 0 |
| 6/2020 | HistoSonics | Series C | 0 |
| 2/2020 | Eximis Surgical | Series A | 0 |
| 1/2020 | Health Scholars | Series B | 0 |
| 12/2019 | SkySpecs | Series C | 0 |
| 4/2019 | HistoSonics | Series C | 0 |
| 11/2018 | Eximis Surgical | Venture Round | 0 |
| 10/2018 | Invenra | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
